{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:07:15Z","timestamp":1788448035036,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770203"],"award-info":[{"award-number":["81770203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670135"],"award-info":[{"award-number":["81670135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870109"],"award-info":[{"award-number":["81870109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7162174"],"award-info":[{"award-number":["7162174"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202191"],"award-info":[{"award-number":["7202191"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00277-020-04156-6","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T17:03:51Z","timestamp":1592845431000},"page":"1883-1893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies"],"prefix":"10.1007","volume":"99","author":[{"given":"Xiao-Ning","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ji","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-9113","authenticated-orcid":false,"given":"Dai-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"20","key":"4156_CR1","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","volume":"127","author":"P Teira","year":"2016","unstructured":"Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ (2016) Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood 127(20):2427\u20132438","journal-title":"Blood"},{"issue":"3","key":"4156_CR2","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","volume":"3","author":"ML Green","year":"2016","unstructured":"Green ML, Leisenring W, Xie H, Mast TC, Cui Y, Sandmaier M, Sorror ML, Goyal S, Ozkok S, Yi J, Sahoo F, Kimball LE, Jerome KR, Marks MA, Boeckh M (2016) Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol 3(3):e119\u2013e127","journal-title":"Lancet Haematol"},{"issue":"11","key":"4156_CR3","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"K Takenaka","year":"2015","unstructured":"Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T (2015) Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan society for hematopoietic cell transplantation transplantation-related complication working group. Biol Blood Marrow Transplant 21(11):2008\u20132016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"4156_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD, Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis 64(1):87\u201391","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4156_CR5","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1172\/JCI45449","volume":"121","author":"M Boeckh","year":"2011","unstructured":"Boeckh M, Geballe AP (2011) Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 121(5):1673\u20131680","journal-title":"J Clin Invest"},{"issue":"12","key":"4156_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.bbmt.2012.07.003","volume":"18","author":"SO Ciurea","year":"2012","unstructured":"Ciurea SO, Mulanovich V, Saliba RM, Bayraktar UD, Jiang Y, Bassett RL, Wang S, Konopleva M, Fernandezvina M, Montes N, Bosque D, Chen J, Rondon G, Alatrash G, Alousi AM, Bashir Q, Korbling M, Qazilbash MH, Parmar S, Shpall EJ, Nieto Y, Hosing C, Kebriaei P, Khouri IF, Popat UR, Lima MD, Champlin RE (2012) Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18(12):1835\u20131844","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"4156_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/pbc.25237","volume":"62","author":"M Qayed","year":"2014","unstructured":"Qayed M, Khurana M, Hilinski J, Gillespie S, McCracken C, Applegate K, Chiang K, Horan J (2014) Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 62(2):364\u2013366","journal-title":"Pediatr Blood Cancer"},{"key":"4156_CR8","doi-asserted-by":"crossref","unstructured":"Dufort G, Castillo L, Pisano S, Castiglioni M, Carolina P, Andrea I, Simon E, Zuccolo S, Schelotto M, Morosini F, Pereira I, Amarillo P, Silveira A, Guerrero L, Ferreira V, Tiscornia A, Mezzano R, Lemos F, Boggia B, Quarnetti A, Decaro J, Dabezies A. (2016) Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center. Bone Marrow Transplant 51(10):1354\u20131360","DOI":"10.1038\/bmt.2016.161"},{"issue":"10","key":"4156_CR9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00277-015-2423-y","volume":"94","author":"J Tischer","year":"2015","unstructured":"Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, B\u00fccklein V, Reibke R, Mumm F, Rieger CT, Hill W, Ledderose G, Stemmler HJ, K\u00f6hnke T, J\u00e4ger G, Kolb HJ, Schmid C, Moosmann A, Hausmann A (2015) Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Ann Hematol 94(10):1677\u20131688","journal-title":"Ann Hematol"},{"issue":"4","key":"4156_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/infdis\/jit475","volume":"209","author":"E Shmueli","year":"2014","unstructured":"Shmueli E, Or R, Shapira MY, Resnick IB, Caplan O, Bdolah-Abram T, Wolf DG (2014) High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation. J Infect Dis 209(4):557\u2013561","journal-title":"J Infect Dis"},{"issue":"10","key":"4156_CR11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","volume":"20","author":"AM Raiola","year":"2014","unstructured":"Raiola AM, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, Bregante S, Van Lint MT, Varaldo R, Ghiso A, Gobbi M, Carella AM, Signori A, Galaverna F, Bacigalupo A (2014) Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transplant 20(10):1573\u20131579","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"4156_CR12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00277-019-03742-7","volume":"98","author":"XN Gao","year":"2019","unstructured":"Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH (2019) Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies. Ann Hematol 98(9):2163\u20132177","journal-title":"Ann Hematol"},{"issue":"8","key":"4156_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","volume":"18","author":"PJ Martin","year":"2012","unstructured":"Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA (2012) First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 18(8):1150\u20131163","journal-title":"Biol Blood Marrow Transplant"},{"key":"4156_CR14","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825\u2013828"},{"issue":"3","key":"4156_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME (2015) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and staging working group report. Biol Blood Marrow Transplant 21(3):389\u2013401","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"4156_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","volume":"40","author":"L Scrucca","year":"2007","unstructured":"Scrucca L, Santucci A, Aversa F (2007) Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 40(4):381\u2013387","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"4156_CR17","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/bmt.2009.359","volume":"45","author":"L Scrucca","year":"2010","unstructured":"Scrucca L, Santucci A, Aversa F (2010) Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 45(9):1388\u20131395","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4156_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12916-019-1393-7","volume":"17","author":"R Lin","year":"2019","unstructured":"Lin R, Wang Y, Huang F, Fan Z, Zhang S, Yang T, Xu Y, Xu N, Xuan L, Ye J, Sun J, Huang X, Liu Q (2019) Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study. BMC Med 17(1):156","journal-title":"BMC Med"},{"issue":"6","key":"4156_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12778","volume":"19","author":"M Ci\u00e1urriz","year":"2017","unstructured":"Ci\u00e1urriz M, Beloki L, Zabalza A, Bandr\u00e9s E, Mansilla C, P\u00e9rez-Valderrama E, Lach\u00e9n M, Rodr\u00edguez-Calvillo M, Ram\u00edrez N, Olavarr\u00eda E (2017) Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 19(6):e12778","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"4156_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003634","volume":"3","author":"T Widmann","year":"2008","unstructured":"Widmann T, Sester U, G\u00e4rtner BC, Schubert J, Pfreundschuh M, K\u00f6hler H, Sester M (2008) Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS One 3(11):e3634","journal-title":"PLoS One"},{"issue":"4","key":"4156_CR21","doi-asserted-by":"publisher","first-page":"E491","DOI":"10.1111\/ctr.12172","volume":"27","author":"F Zallio","year":"2013","unstructured":"Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A (2013) Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation. Clin Transpl 27(4):E491\u2013E497","journal-title":"Clin Transpl"},{"issue":"10","key":"4156_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/ctr.12593","volume":"29","author":"J Liu","year":"2015","unstructured":"Liu J, Yan C, Zhang C, Xu L, Liu Y, Huang X (2015) Late-onset Epstein-Barr virus-related disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation is associated with impaired early recovery of T and B lymphocytes. Clin Transpl 29(10):904\u2013910","journal-title":"Clin Transpl"},{"issue":"4","key":"4156_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/JCM.01670-06","volume":"45","author":"XY Han","year":"2007","unstructured":"Han XY (2007) Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer. J Clin Microbiol 45(4):1126\u20131132","journal-title":"J Clin Microbiol"},{"key":"4156_CR24","doi-asserted-by":"crossref","unstructured":"Stern L, Withers B, Avdic S, Gottlieb D, Abendroth A, Blyth E, Slobedman B (2019) Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients. Front Microbiol 10:1186","DOI":"10.3389\/fmicb.2019.01186"},{"issue":"10","key":"4156_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/bmt.2008.238","volume":"42","author":"LR Wang","year":"2008","unstructured":"Wang LR, Dong LJ, Zhang MJ, Lu DP (2008) Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 42(10):673\u2013677","journal-title":"Bone Marrow Transplant"},{"key":"4156_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcv.2015.12.003","volume":"75","author":"Y Chen","year":"2016","unstructured":"Chen Y, Xu LP, Liu KY, Chen H, Chen YH, Zhang XH, Wang Y, Wang FR, Han W, Wang JZ, Yan CH, Huang XJ (2016) Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus. J Clin Virol 75:10\u201315","journal-title":"J Clin Virol"},{"issue":"12","key":"4156_CR27","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1182\/blood-2010-12-290403","volume":"117","author":"JM Coghill","year":"2011","unstructured":"Coghill JM, Sarantopoulos S, Moran TP, Murphy WJ, Blazar BR, Serody JS (2011) Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood 117(12):3268\u20133276","journal-title":"Blood"},{"issue":"5","key":"4156_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD, Ross RS, Horn PA, Schnittger S, Beelen DW (2011) Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus leukemia effect in acute myeloid leukemia patients. Blood 118(5):1402\u20131412","journal-title":"Blood"},{"issue":"2","key":"4156_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00277-014-2190-1","volume":"94","author":"JE Jang","year":"2015","unstructured":"Jang JE, Kim SJ, Cheong JW, Hyun SY, Kim YD, Kim YR, Kim JS, Min YH (2015) Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia. Ann Hematol 94(2):275\u2013282","journal-title":"Ann Hematol"},{"issue":"10","key":"4156_CR30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/bmt.2013.49","volume":"48","author":"S Ito","year":"2013","unstructured":"Ito S, Pophali P, Co W, Koklanaris EK, Superata J, Fahle GA, Childs R, Battiwalla M, Barrett AJ (2013) CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant 48(10):1313\u20131316","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"4156_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","volume":"122","author":"ML Green","year":"2013","unstructured":"Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM, Riddell SR, Boeckh M (2013) CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 122(7):1316\u20131324","journal-title":"Blood"},{"issue":"6","key":"4156_CR32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bbmt.2014.02.015","volume":"20","author":"J Mariotti","year":"2014","unstructured":"Mariotti J, Maura F, Spina F, Roncari L, Dodero A, Farina L, Montefusco V, Carniti C, Sarina B, Patriarca F, Rambaldi A, Onida F, Olivieri A, Zallio F, Corradini P (2014) Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 20(6):885\u2013890","journal-title":"Biol Blood Marrow Transplant"},{"key":"4156_CR33","doi-asserted-by":"crossref","unstructured":"Jeljeli M, Gu\u00b4 erin-El Khourouj V, Porcher R, Fahd M, Leveille S, Yakouben K, Ouacheechardin M, Legoff J, Cordeiro DJ, Pedron B, Baruchel A, Dalle J, Sterkers G (2014) Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children. Br J Haematol 166(2):229\u2013239","DOI":"10.1111\/bjh.12875"},{"key":"4156_CR34","doi-asserted-by":"crossref","unstructured":"Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J, Soci\u00e9 G, Schwerdtfeger R, Kr\u00f6ger N, Ganser A, Niederwieser D, Polge E, Blau IW, Mohty M (2013) CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT. Blood 122(19):3359\u20133364","DOI":"10.1182\/blood-2013-05-499830"},{"issue":"6","key":"4156_CR35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1182\/bloodadvances.2019000814","volume":"4","author":"S Kaito","year":"2020","unstructured":"Kaito S, Nakajima Y, Hara K, Toya T, Nishida T, Uchida N, Mukae J, Fukuda T, Ozawa Y, Tanaka M, Ikegame K, Katayama Y, Kuriyama T, Kanda J, Atsuta Y, Ogata M, Taguchi A, Ohashi K (2020) Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation. Blood Adv 4(6):1051\u20131061","journal-title":"Blood Adv"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04156-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:31:39Z","timestamp":1624318299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04156-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"17 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}